AVNRT

The Worldwide Electrophysiology Industry is Expected to Reach $11.9 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 21, 2022
Health, Medical Devices, Cardiology, CAGR, Population, Stryker, Union, WHO, Atrial flutter, Budget, World, CE marking, Risk, Smartphone, Dyslipidemia, Hospital, USD, Disease, Hypertension, Stroke, EP, World Health Organization, Incidence, AED, Prevalence, Heart, Canadian International Council, CVD, Death, Person, American Heart Association, Heart failure, Suds, WPW, Pandemic, Ban on caffeinated alcoholic drinks, Industry, FDA, Abbott Laboratories, Atrial fibrillation, Electrophysiology, Adoption, AVNRT, Catheter, Laboratory, Diagnosis, Medical tourism, Diabetes, US Foods, Mortality, Obesity, Cardiovascular disease, Arrhythmia, ICE, ICM, Tobacco smoking, Food, Product life-cycle theory, ICDS, Awareness, Liquor, Medical device, Pharmaceutical industry, Recycling, Implantable cardioverter-defibrillator

The Global Electrophysiology Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 8.8% CAGR during the forecast period.

Key Points: 
  • The Global Electrophysiology Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 8.8% CAGR during the forecast period.
  • Electrophysiology (EP) devices are a type of medical equipment that is used to diagnose and treat cardiovascular problems.
  • In the event of an emergency, these devices send & receive electrical signals to & from the heart to regulate the heartbeat.
  • According to the WHO organization, CVD expenses is expected to reach USD 1,044 billion by 2030, up from USD 863 billion in 2010.

Electrophysiology Market worth $11.6 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, March 2, 2022
People, Adoption, Investment, Heart, Arrhythmia, Population, Heart failure, LLC, Smoking, Atrial fibrillation, COVID-19, AF, Physician, ICE, VisionMap A3 Digital Mapping System, Wolff–Parkinson–White syndrome, Ageing, Diagnosis, CVD, Government, Awareness, Catheter, Electrophysiology, Ventricular fibrillation, EP, Incidence, Conditional sentence, Supraventricular tachycardia, Degenerative disease, Blood, GE Healthcare, SVT, WPW, Obesity, Drinking, MRI, Johnson & Johnson, Patient, Hospital, Prevalence, AVNRT, RF, Growth, Tachycardia, Atrial flutter, CAGR, Boston Scientific, Stroke, Pharmaceutical industry, Medical device, Synthetic rubber, Medical imaging, Liquor, Medtronic

The reuse & reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market.

Key Points: 
  • The reuse & reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market.
  • The EP laboratory devices segment commanded the largest share of 57.0% of the electrophysiology market in 2021.
  • Electrophysiology laboratory devices are most commonly used by clinicians or physicians to diagnose and treat complex cardiac arrhythmias during electrophysiology tests.
  • Electrophysiology Ablation Cathers accounts to have the second-largest share of the gobal electrophysiology market are expected to register a growth rate of 8.8% during the forecasted period of 2022 to 2027.

Electrophysiology Market worth $11.6 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, March 2, 2022
People, Adoption, Investment, Heart, Arrhythmia, Population, Heart failure, LLC, Smoking, Atrial fibrillation, COVID-19, AF, Physician, ICE, VisionMap A3 Digital Mapping System, Wolff–Parkinson–White syndrome, Ageing, Diagnosis, CVD, Government, Awareness, Catheter, Electrophysiology, Ventricular fibrillation, EP, Incidence, Conditional sentence, Supraventricular tachycardia, Degenerative disease, Blood, GE Healthcare, SVT, WPW, Obesity, Drinking, MRI, Johnson & Johnson, Patient, Hospital, Prevalence, AVNRT, RF, Growth, Tachycardia, Atrial flutter, CAGR, Boston Scientific, Stroke, Pharmaceutical industry, Medical device, Synthetic rubber, Medical imaging, Liquor, Medtronic

The reuse & reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market.

Key Points: 
  • The reuse & reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market.
  • The EP laboratory devices segment commanded the largest share of 57.0% of the electrophysiology market in 2021.
  • Electrophysiology laboratory devices are most commonly used by clinicians or physicians to diagnose and treat complex cardiac arrhythmias during electrophysiology tests.
  • Electrophysiology Ablation Cathers accounts to have the second-largest share of the gobal electrophysiology market are expected to register a growth rate of 8.8% during the forecasted period of 2022 to 2027.

Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition

Retrieved on: 
Friday, February 18, 2022
Lightheadedness, Pediatrics, Prevalence, Congenital heart block, U.S. Securities and Exchange Commission, Adult, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Cardiology, Catheter ablation, CLIN, Electrophysiology, PACES, Comparison, Supraventricular tachycardia, Health, Hell, Recurrence, Veni, vidi, vici, Tachycardia, Twitter, Learning curve, Cryoablation, Heart, NA, Journal of Cardiovascular Electrophysiology, Risk, Radiofrequency ablation, Safety, Pain, LinkedIn, Syncope, AF, Cardiovascular disease, Atrial fibrillation, Palpitations, Arrhythmia, NYSE, Patient, Food, Adolescence, Solution, Security (finance), AVNRT, PACE, Radiation, FDA, Coronary sinus, NK, SVT, Pharmaceutical industry, Medical imaging, Medicine, Medical device, Silviculture, Wood drying, Mortar (masonry), Medtronic, Young, Chiesa

AVNRT is the most common form of supraventricular tachycardia (SVT), and is a life-threatening abnormal heart rhythm, with 89,000 cases each year and growing.

Key Points: 
  • AVNRT is the most common form of supraventricular tachycardia (SVT), and is a life-threatening abnormal heart rhythm, with 89,000 cases each year and growing.
  • The Freezor family of cryoablation catheters also includes the Freezor MAX cardiac cryoablation catheter, which is approved for use in conjunction with the Arctic Front Advance cryoballoon for the treatment of atrial fibrillation (AF).
  • Medtronic has pioneered cryoablation technology, with an industry-leading and extensive body of evidence, including proven safety and efficacy in treating AF and AVNRT.
  • Experience and results during transition from radiofrequency ablation to cryoablation for treatment of pediatric atrioventricular nodal reentrant tachycardia PACE Pacing Clin.

International Journal of Cardiology Publishes Data Demonstrating Superior Outcomes of Stereotaxis Robotic Cardiac Ablation in Pediatric Patients

Retrieved on: 
Tuesday, October 12, 2021
Freedom, Patient, AVRT, AVNRT, Robotics, Arrhythmia, Heart, GLOBE, SVT, Robotic magnetic navigation, Tachycardia, RF, NYSE, Erasmus MC, Recurrence, Cryoablation, Comparison, RTS, Heart failure, Canadian International Council, RMN, Medical device

The 223-patient study, conducted at Erasmus Medical Center in Rotterdam, the Netherlands, compared Robotic Magnetic Navigation (RMN) guided cardiac ablation to manual radiofrequency (RF) ablation and manual cryoablation.

Key Points: 
  • The 223-patient study, conducted at Erasmus Medical Center in Rotterdam, the Netherlands, compared Robotic Magnetic Navigation (RMN) guided cardiac ablation to manual radiofrequency (RF) ablation and manual cryoablation.
  • We are excited to share data from this large long-term comparative study, said Dr. Anne-Marie Noten, author of the publication.
  • It builds upon the significant body of evidence supporting the clinical value of robotics for arrhythmia patients, particularly the most vulnerable patients with complex disease.
  • Although cardiac ablation is a common treatment for AV(N)RT, there is risk of procedural complications, and the impact of procedural radiation on pediatric patients is a concern.